Pneumocystis carinii pneumonia in scid mice induced by viable organisms propagated in vitro
- PMID: 8890219
- PMCID: PMC174425
- DOI: 10.1128/iai.64.11.4643-4647.1996
Pneumocystis carinii pneumonia in scid mice induced by viable organisms propagated in vitro
Abstract
Pneumocystis carinii pneumonia remains a major cause of morbidity and mortality in human immunodeficiency virus-infected individuals, despite the widespread use of prophylaxis and the development of new chemotherapeutic agents. The study of P. carinii and of pulmonary host defenses directed against it has been limited by lack of reliable, reproducible methods to obtain pure populations of organisms in useful quantities. While recent success has been achieved with cultures of rat P. carinii organisms, cultures of mouse P. carinii organisms have not been successful. Experiments were performed to determine whether P. carinii organisms derived from mice could be propagated in vitro. Mouse P. carinii organisms, obtained from the lungs of chronically infected athymic mice, were inoculated into spinner flasks containing HEL299 feeder cells seated on microcarrier beads. The numbers of mouse P. carinii organisms increased significantly over 7 days in culture. To test the viability and pathogenicity of these cultured organisms, P. carinii organisms were harvested after 7 days of culture and were inoculated intratracheally into susceptible scid mice. Four weeks after inoculation, scid mice developed uniformly severe P. carinii pneumonia. These studies demonstrate for the first time that mouse P. carinii organisms can be propagated in vitro. Furthermore, cultured mouse P. carinii organisms maintain their pathogenicity in an in vivo model system. This culture system will have important applications in the study of P. carinii biology and in the study of host defenses directed against this important opportunistic pathogen.
Similar articles
-
An improved method for the prolonged maintenance of Pneumocystis carinii in vitro.J Infect Dis. 1993 Jun;167(6):1470-3. doi: 10.1093/infdis/167.6.1470. J Infect Dis. 1993. PMID: 8501343
-
Multiplication of human-derived Pneumocystis carinii in severe combined immunodeficient (SCID) mice.Experientia. 1992 Jan 15;48(1):63-6. doi: 10.1007/BF01923610. Experientia. 1992. PMID: 1737579
-
Nitric oxide and host defense against Pneumocystis carinii infection in a mouse model.J Infect Dis. 1996 Feb;173(2):432-9. doi: 10.1093/infdis/173.2.432. J Infect Dis. 1996. PMID: 8568306
-
Pneumocystis carinii pneumonia: the status of Pneumocystis biochemistry.Int J Parasitol. 1998 Jan;28(1):65-84. doi: 10.1016/s0020-7519(97)00179-3. Int J Parasitol. 1998. PMID: 9504336 Review.
-
Animal models of pneumocystosis.FEMS Immunol Med Microbiol. 1998 Sep;22(1-2):163-8. doi: 10.1111/j.1574-695X.1998.tb01201.x. FEMS Immunol Med Microbiol. 1998. PMID: 9792075 Review.
Cited by
-
Pneumocystis jirovecii Rtt109, a novel drug target for Pneumocystis pneumonia in immunosuppressed humans.Antimicrob Agents Chemother. 2014 Jul;58(7):3650-9. doi: 10.1128/AAC.02637-14. Epub 2014 Apr 14. Antimicrob Agents Chemother. 2014. PMID: 24733475 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources